ADVERTISEMENTREMOVE AD
Members Only
lock close icon

Conflicting Medicinal Claims On Patanjali’s Sharbat Bottles: USFDA

Patanjali products have more medicinal claims in India than those to be exported to America.

Published: 
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large

Labels on Patanjali's two sharbat products, earmarked to be sold within India, were found to be having "additional medicinal and dietary market claims" as compared to the ones on bottles set aside for export to America, according to the US health regulator.

“Firm has separate production and packaging areas for exported and domestic products.”
The United States and Food and Drug Administration (USFDA) report.
Become a Member to unlock
  • Access to all paywalled content on site
  • Ad-free experience across The Quint
  • Listen to paywalled content
  • Early previews of our Special Projects
×
×